美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=INVEGA"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
INVEGA 021999 001 NDA PALIPERIDONE TABLET, EXTENDED RELEASE;ORAL 3MG Yes No 2006/12/19 2006/12/19 JANSSEN PHARMS Prescription
INVEGA 021999 002 NDA PALIPERIDONE TABLET, EXTENDED RELEASE;ORAL 6MG Yes Yes 2006/12/19 2006/12/19 JANSSEN PHARMS Prescription
INVEGA 021999 003 NDA PALIPERIDONE TABLET, EXTENDED RELEASE;ORAL 9MG Yes No 2006/12/19 2006/12/19 JANSSEN PHARMS Prescription
INVEGA 021999 004 NDA PALIPERIDONE TABLET, EXTENDED RELEASE;ORAL 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No 2006/12/19 2006/12/19 JANSSEN PHARMS Discontinued
INVEGA 021999 006 NDA PALIPERIDONE TABLET, EXTENDED RELEASE;ORAL 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No 2006/12/19 2008/08/26 JANSSEN PHARMS Discontinued
INVEGA 022043 001 NDA PALIPERIDONE TABLET, EXTENDED RELEASE; ORAL 3MG No No 2007/04/27 -- JANSSEN LP Prescription
INVEGA 022043 002 NDA PALIPERIDONE TABLET, EXTENDED RELEASE; ORAL 6MG No No 2007/04/27 -- JANSSEN LP Prescription
INVEGA 022043 003 NDA PALIPERIDONE TABLET, EXTENDED RELEASE; ORAL 9MG No No 2007/04/27 -- JANSSEN LP Prescription
INVEGA 022043 004 NDA PALIPERIDONE TABLET, EXTENDED RELEASE; ORAL 12MG No No 2007/04/27 -- JANSSEN LP Prescription
INVEGA SUSTENNA 022264 001 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 39MG/0.25ML (39MG/0.25ML) Yes No 2009/07/31 2009/07/31 JANSSEN PHARMS Prescription
INVEGA SUSTENNA 022264 002 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 78MG/0.5ML (78MG/0.5ML) Yes No 2009/07/31 2009/07/31 JANSSEN PHARMS Prescription
INVEGA SUSTENNA 022264 003 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 117MG/0.75ML (117MG/0.75ML) Yes No 2009/07/31 2009/07/31 JANSSEN PHARMS Prescription
INVEGA SUSTENNA 022264 004 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 156MG/ML (156MG/ML) Yes Yes 2009/07/31 2009/07/31 JANSSEN PHARMS Prescription
INVEGA SUSTENNA 022264 005 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 234MG/1.5ML (156MG/ML) Yes No 2009/07/31 2009/07/31 JANSSEN PHARMS Prescription
INVEGA TRINZA 207946 001 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 273MG/0.875ML (273MG/0.875ML) Yes Yes 2015/05/18 2015/05/18 JANSSEN PHARMS Prescription
INVEGA TRINZA 207946 002 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 410MG/1.315ML (311.79MG/ML) Yes Yes 2015/05/18 2015/05/18 JANSSEN PHARMS Prescription
INVEGA TRINZA 207946 003 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 546MG/1.75ML (312MG/ML) Yes Yes 2015/05/18 2015/05/18 JANSSEN PHARMS Prescription
INVEGA TRINZA 207946 004 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 819MG/2.625ML (312MG/ML) Yes Yes 2015/05/18 2015/05/18 JANSSEN PHARMS Prescription
INVEGA HAFYERA 207946 005 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 1.092GM/3.5ML (312MG/ML) Yes No 2015/05/18 2021/08/30 JANSSEN PHARMS Prescription
INVEGA HAFYERA 207946 006 NDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 1.560GM/5ML (312MG/ML) Yes No 2015/05/18 2021/08/30 JANSSEN PHARMS Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database